Skip to main content

Table 1 Univariate and multivariate Cox analysis based on EXTL3 and clinicopathologic characteristics of OS for PCa

From: EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms

id

Univariate analysis

Multivariate analysis

HR

HR.95L

HR.95H

P value

HR

HR.95L

HR.95H

P value

Age

0.972997

0.855266

1.106936

0.677408

1.006836

0.886295

1.14377

0.916609

Staged_T

2.94079

0.470691

18.3735

0.24855

4.806752

0.117532

196.5834

0.406996

Staged_N

5.648441

0.791027

40.3335

0.084305

2.112223

0.021796

204.6929

0.748647

Cancer_status

5.238172

0.868125

31.60655

0.070957

8.208636

0.511568

131.716

0.137112

Lymphnodes

1.981361

0.925045

4.243892

0.078496

0.666342

0.043656

10.17071

0.770338

Gleason_score

1.31901

0.514518

3.381395

0.564308

0.919313

0.253578

3.332847

0.89813

Psa_value

1.213885

1.031111

1.429057

0.019916

1.28322

0.893096

1.843759

0.17748

EXTL3

0.201004

0.051223

0.788756

0.021439

0.119168

0.021608

0.657197

0.014614